• Home
  • About
    • Background
    • Management
    • R&D
    • Partners and Subsidiaries
    • Customer reviews
  • CRO Services
    • Cell Based Assays
      • Ex vivo T cell activation
      • On demand assays
    • Disease Models
      • Models of Rheumatoid Arthritis (RA)
      • Models of Multiple Sclerosis (MS)
      • Models of Guillain-Barré Syndrome (GBS)
      • Models of Systemic Lupus Erythematosus (SLE)
      • Models of Cytokine storm
      • Models of Psoriasis and Psoriatic Arthritis
      • Mouse model of Parkinson´s disease (PD)
    • Magnetic resonance imaging (MRI)
    • Tissue collection & analysis
      • Ex vivo T cell activation
      • On demand assays
    • Ncf1 mutated mice
  • News
    • News
    • Scientific Reports
  • Career
  • Contact
  • Home
  • About
    • Background
    • Management
    • R&D
    • Partners and Subsidiaries
    • Customer reviews
  • CRO Services
    • Cell Based Assays
      • Ex vivo T cell activation
      • On demand assays
    • Disease Models
      • Models of Rheumatoid Arthritis (RA)
      • Models of Multiple Sclerosis (MS)
      • Models of Guillain-Barré Syndrome (GBS)
      • Models of Systemic Lupus Erythematosus (SLE)
      • Models of Cytokine storm
      • Models of Psoriasis and Psoriatic Arthritis
      • Mouse model of Parkinson´s disease (PD)
    • Magnetic resonance imaging (MRI)
    • Tissue collection & analysis
      • Ex vivo T cell activation
      • On demand assays
    • Ncf1 mutated mice
  • News
    • News
    • Scientific Reports
  • Career
  • Contact

Seasons greetings

December 21, 2020 | Latest News
  • Welcome Tekla!
  • Are you our new collegue?

Address

Redoxis AB
Medicon Village
Scheelevägen 2
223 81 Lund, Sweden

Contact

Tel: +46 707 25 95 65
info@redoxis.com

About Redoxis AB

Redoxis is a CRO with core expertise and focus on preclinical drug development and efficacy evaluation in models of autoimmune disease. With the roots in academic research we are continuously updating our portfolio of models and are connected to the latest immunology research. We take great pride in personal communication and commitment in our studies – for the benefit of your preclinical project! 

Copyright © 2021 Redoxis AB